Cryptosporidium parvum sporozoite pellicle antigen recognized by a neutralizing monoclonal antibody is a β-mannosylated glycolipid

Infection and Immunity

Volumn 67, Issue 3, 1999, Pages 1317-1322

  Riggs, Michael W ^a   McNeil, Michael R ^b   Perryman, Lance E ^c   Stone, Alice L ^a   Scherman, Michael S ^b   O'Connor, Roberta M ^d  

^a UNIVERSITY OF ARIZONA   (United States)

^b Department of Environmental and Radiological Health Sciences   (United States)

^c NORTH CAROLINA STATE UNIVERSITY   (United States)

^d UNIVERSITY OF FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CPS 500 ANTIGEN; GLYCOLIPID; MONOCLONAL ANTIBODY; PARASITE ANTIGEN; UNCLASSIFIED DRUG;

ANIMAL DISEASE; ANTIGEN RECOGNITION; ARTICLE; BACTERIUM ADHERENCE; CELLULAR DISTRIBUTION; CRYPTOSPORIDIOSIS; CRYPTOSPORIDIUM PARVUM; DIARRHEA; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IMMUNOELECTRON MICROSCOPY; MEROZOITE; NONHUMAN; PRIORITY JOURNAL; SPOROZOITE; STRUCTURE ACTIVITY RELATION;

EID: 0033044099     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.67.3.1317-1322.1999     Document Type: Article

References (36)

1. Alving, C. R. 1981. Immune reactions of lipids and lipid model membranes, vol. 4. In M. Sela (ed.), Antigens. Academic Press, London, United Kingdom.
2. Arrowood, M. J., J. R. Mead, J. L. Mahrt, and C. R. Sterling. 1989. Effects of immune colostrum and orally administered antisporozoite monoclonal antibodies on the outcome of Cryptosporidium parvum infections in neonatal mice. Infect. Immun. 57:2283-2288.
3. Arrowood, M. J., and C. R. Sterling. 1987. Isolation of Cryptosporidium oocysts and sporozoites using discontinuous sucrose and isopycnic Percoll gradients. J. Parasitol. 73:314-319.
4. Arrowood, M. J., C. R. Sterling, and M. C. Healey. 1991. Immunofluorescent microscopical visualization of trails left by gliding Cryptosporidium parvum sporozoites. J. Parasitol. 77:315-317.
5. Bjorneby, J. M., M. W. Riggs, and L. E. Perryman. 1990. Cryptosporidium parvum merozoites share neutralization-sensitive epitopes with sporozoites. J. Immunol. 145:298-304.
6. Blagburn, B. L., and R. Soave. 1997. Prophylaxis and chemotherapy, p. 111-123. In R. Fayer (ed.), Cryptosporidium and cryptosporidiosis. CRC Press, Boca Raton, Fla.
7. Bligh, E. G., and W. J. Dyer. 1959. A rapid method of total lipid extraction and purification. Can. J. Biochem. Physiol. 37:911-917.
8. Chambers, R. E., and J. R. Clamp. 1971. An assessment of methanolysis and other factors used in the analysis of carbohydrate-containing materials. Biochem. J. 125:1009-1018.
9. Enriquez, F. J., and M. W. Riggs. 1998. Role of immunoglobulin A monoclonal antibodies against P23 in controlling murine Cryptosporidium parvum infection. Infect. Immun. 66:4469-4473.
10. Fayer, R., C. A. Speer, and J. P. Dubey. 1997. The general biology of Cryptosporidium, p. 1-33. In R. Fayer (ed.), Cryptosporidium and cryptosporidiosis. CRC Press, Boca Raton, Fla.
11. Goding, J. W. 1996. Monoclonal antibodies: principles and practice, p. 83. Academic Press, London, United Kingdom.
12. Gut, J., and R. G. Nelson. 1994. Cryptosporidium parvum sporozoites deposit trails of 11A5 antigen during gliding locomotion and shed 11A5 antigen during invasion of MDCK cells in vitro. J. Eukaryot. Microbiol. 41:42S-43S.
13. Heine, J., J. F. L. Pohlenz, H. W. Moon, and G. N. Woode. 1984. Enteric lesions and diarrhea in gnotobiotic calves monoinfected with Cryptosporidium species. J. Infect. Dis. 150:768-775.
14. Jenkins, M. C., and R. Fayer. 1995. Cloning and expression of cDNA encoding an antigenic Cryptosporidium parvum protein. Mol. Biochem. Parasitol. 71:149-152.
15. Kates, M. 1986. Techniques of lipidology: isolation, analysis, and identification of lipids, p. 80-109. In R. H. Burdon and P. H. van Knippenberg (ed.), Laboratory techniques in biochemistry and molecular biology. Elsevier, Amsterdam, The Netherlands.
16. Langer, R. C., and M. W. Riggs. 1996. Neutralizing monoclonal antibody protects against Cryptosporidium parvum infection in vitro by inhibiting sporozoite attachment and invasion. J. Eukaryot. Microbiol. 43:76S-77S.
17. Luft, B. J., D. Payne, D. Woodmansee, and C. W. Kim. 1987. Characterization of the Cryptosporidium antigens from sporulated oocysts of Cryptosporidium parvum. Infect. Immun. 55:2436-2441.
18. Lumb, R., K. Smith, P. J. O'Donoghue, and J. A. Lanser. 1988. Ultrastructure of the attachment of Cryptosporidium sporozoites to tissue cultures. Parasitol. Res. 74:531-536.
19. Mitschler, R. R., R. Welti, and S. J. Upton. 1994. A comparative study of lipid compositions of Cryptosporidium parvum (Apicomplexa) and Madin-Darby bovine kidney cells. J. Eukaryot. Microbiol. 41:8-12.
20. Perryman, L. E., D. P. Jasmer, M. W. Riggs, S. G. Bohnet, T. C. McGuire, and M. J. Arrowood. 1996. A cloned gene of Cryptosporidium parvum encodes neutralization-sensitive epitopes. Mol. Biochem. Parasitol. 80:137-147.
21. Perryman, L. E., M. W. Riggs, P. H. Mason, and R. Fayer. 1990. Kinetics of Cryptosporidium parvum sporozoite neutralization by monoclonal antibodies, immune bovine serum, and immune bovine colostrum. Infect. Immun. 58: 257-259.
22. r Cryptosporidium parvum sporozoite glycoprotein recognized by protective hyperimmune bovine colostral immunoglobulin. Infect. Immun. 60:5132-5138.
23. Riggs, M. W. Unpublished data.
24. Riggs, M. W. 1997. Immunology: host response and development of passive immunotherapy and vaccines, p. 130-154. In R. Fayer (ed.), Cryptosporidium and cryptosporidiosis. CRC Press, Boca Raton, Fla.
25. Riggs, M. W., V. A. Cama, H. L. Leary, Jr., and C. R. Sterling. 1994. Bovine antibody against Cryptosporidium parvum elicits a circumsporozoite precipitate-like reaction and has immunotherapeutic effect against persistent cryptosporidiosis in SCID mice. Infect. Immun. 62:1927-1939.
26. Riggs, M. W., T. C. McGuire, P. H. Mason, and L. E. Perryman. 1989. Neutralization-sensitive epitopes are exposed on the surface of infectious Cryptosporidium parvum sporozoites. J. Immunol. 143:1340-1345.
27. Riggs, M. W., and L. E. Perryman. 1987. Infectivity and neutralization of Cryptosporidium parvum sporozoites. Infect. Immun. 55:2081-2087.
28. Riggs, M. W., A. L. Stone, P. A. Yount, R. C. Langer, M. J. Arrowood, and D. L. Bentley. 1997. Protective monoclonal antibody defines a circumsporozoite-like glycoprotein exoantigen of Cryptosporidium parvum sporozoites and merozoites. J. Immunol. 158:1787-1795.
29. Sam-Yellowe, T. Y. 1996. Rhoptry organelles of the Apicomplexa: their role in host cell invasion and intracellular survival. Parasitol. Today 12:308-316.
30. Stewart, M. J., and J. P. Vanderberg. 1988. Malaria sporozoites leave behind trails of circumsporozoite protein during gliding motility. J. Protozool. 35: 389-393.
31. Tilley, M., and S. J. Upton. 1994. Both CP15 and CP25 are left as trails behind gliding sporozoites of Cryptosporidium parvum (Apicomplexa). FEMS Microbiol. Lett. 120:275-278.
32. Tilley, M., S. J. Upton, R. Fayer, J. R. Barta, C. E. Chrisp, P. S. Freed, B. L. Blagburn, B. C. Anderson, and S. M. Barnard. 1991. Identification of a 15-kilodalton surface glycoprotein on sporozoites of Cryptosporidium parvum. Infect. Immun. 59:1002-1007.
33. Uhl, E. W., R. M. O'Connor, L. E. Perryman, and M. W. Riggs. 1992. Neutralization-sensitive epitopes are conserved among geographically diverse isolates of Cryptosporidium parvum. Infect. Immun. 60:1703-1706.
34. Ungar, B. L. P. 1990. Cryptosporidiosis in humans (Homo sapiens), p. 60-82. In J. P. Dubey, C. A. Speer, and R. Fayer (ed.), Cryptosporidiosis of man and animals. CRC Press, Boca Raton, Fla.
35. Vliegenthart, J. F. G., and J. Montreuil. 1995. Primary structure of glycoprotein glycans, p. 13-28. In J. Montreuil and J. F. G. Vliegenthart (ed.), Glycoproteins. Elsevier, Amsterdam, The Netherlands.
36. Woodward, M. P., W. W. Young, Jr., and R. A. Bloodgood. 1985. Detection of monoclonal antibodies specific for carbohydrate epitopes using periodate oxidation. J. Immunol. Methods 78:143-153.